TMEM59L and neoplasm: Future investigations should focus on identifying the upstream regulators of TMEM59L in CRC, particularly in metastatic versus primary lesions, and clarify how these regulatory networks converge on TMEM59L to modulate its function across different tumor stages—a limitation acknowledged in this work.